President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps consumers afford clean cars while supporting the U.S. auto industry.
GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis.
BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Epithelial Ovarian Cancer.
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback